Exact Mass: 494.161731
Exact Mass Matches: 494.161731
Found 103 metabolites which its exact mass value is equals to given mass value 494.161731
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
6,6-(2-Methyl-1,5-dioxopentane-1,5-diyl)bis[1,3-dimethylpteridine-2,4(1H,3H)-dione]
2,5-di-O-beta-D-glucopyranosyloxy-1,3-dimethoxybenzene
4-hydroxy-3,5-dimethoxyphenyl beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside|4-hydroxy-3,5-dimethoxyphenyl-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside
Cys Met Asn Gln
Cys Met Gln Asn
Cys Asn Met Gln
Cys Asn Gln Met
Cys Gln Met Asn
Cys Gln Asn Met
Asp Glu Met Thr
C18H30N4O10S (494.16825600000004)
Asp Glu Thr Met
C18H30N4O10S (494.16825600000004)
Asp Met Glu Thr
C18H30N4O10S (494.16825600000004)
Asp Met Thr Glu
C18H30N4O10S (494.16825600000004)
Asp Thr Glu Met
C18H30N4O10S (494.16825600000004)
Asp Thr Met Glu
C18H30N4O10S (494.16825600000004)
Glu Asp Met Thr
C18H30N4O10S (494.16825600000004)
Glu Asp Thr Met
C18H30N4O10S (494.16825600000004)
Glu Glu Met Ser
C18H30N4O10S (494.16825600000004)
Glu Glu Ser Met
C18H30N4O10S (494.16825600000004)
Glu Met Asp Thr
C18H30N4O10S (494.16825600000004)
Glu Met Glu Ser
C18H30N4O10S (494.16825600000004)
Glu Met Ser Glu
C18H30N4O10S (494.16825600000004)
Glu Met Thr Asp
C18H30N4O10S (494.16825600000004)
Glu Ser Glu Met
C18H30N4O10S (494.16825600000004)
Glu Ser Met Glu
C18H30N4O10S (494.16825600000004)
Glu Thr Asp Met
C18H30N4O10S (494.16825600000004)
Glu Thr Met Asp
C18H30N4O10S (494.16825600000004)
Met Cys Asn Gln
Met Cys Gln Asn
Met Asp Glu Thr
C18H30N4O10S (494.16825600000004)
Met Asp Thr Glu
C18H30N4O10S (494.16825600000004)
Met Glu Asp Thr
C18H30N4O10S (494.16825600000004)
Met Glu Glu Ser
C18H30N4O10S (494.16825600000004)
Met Glu Ser Glu
C18H30N4O10S (494.16825600000004)
Met Glu Thr Asp
C18H30N4O10S (494.16825600000004)
Met Asn Cys Gln
Met Asn Gln Cys
Met Gln Cys Asn
Met Gln Asn Cys
Met Ser Glu Glu
C18H30N4O10S (494.16825600000004)
Met Thr Asp Glu
C18H30N4O10S (494.16825600000004)
Met Thr Glu Asp
C18H30N4O10S (494.16825600000004)
Asn Cys Met Gln
Asn Cys Gln Met
Asn Met Cys Gln
Asn Met Gln Cys
Asn Gln Cys Met
Asn Gln Met Cys
Gln Cys Met Asn
Gln Cys Asn Met
Gln Met Cys Asn
Gln Met Asn Cys
Gln Asn Cys Met
Gln Asn Met Cys
Ser Glu Glu Met
C18H30N4O10S (494.16825600000004)
Ser Glu Met Glu
C18H30N4O10S (494.16825600000004)
Ser Met Glu Glu
C18H30N4O10S (494.16825600000004)
Thr Asp Glu Met
C18H30N4O10S (494.16825600000004)
Thr Asp Met Glu
C18H30N4O10S (494.16825600000004)
Thr Glu Asp Met
C18H30N4O10S (494.16825600000004)
Thr Glu Met Asp
C18H30N4O10S (494.16825600000004)
Thr Met Asp Glu
C18H30N4O10S (494.16825600000004)
Thr Met Glu Asp
C18H30N4O10S (494.16825600000004)
Spectinomycin hydrochloride
C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
N-(3,4-dimethylphenyl)-2-[[5-[[(4,6-dimethyl-2-pyrimidinyl)thio]methyl]-4-(2-furanylmethyl)-1,2,4-triazol-3-yl]thio]acetamide
[4-[2-(3-Chlorophenyl)-5-phenyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]-pyridin-4-ylmethanone
3-{4-[(E)-2-(1H-Benzoimidazol-2-yl)-2-cyano-vinyl]-1-phenyl-1H-pyrazol-3-yl}-N,N-dimethyl-benzenesulfonamide
[(8S,9R,10S)-9-[4-[(E)-2-phenylethenyl]phenyl]-6-thiophen-2-ylsulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
2-[(3R,6aR,8S,10aR)-1-(3-fluorophenyl)sulfonyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(pyrimidin-4-ylmethyl)acetamide
2-[(3R,6aS,8S,10aS)-1-(3-fluorophenyl)sulfonyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-pyrimidinylmethyl)acetamide
[(8R,9S,10S)-9-[4-[(E)-2-phenylethenyl]phenyl]-6-thiophen-2-ylsulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
2-[(3R,6aR,8R,10aR)-1-(3-fluorophenyl)sulfonyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-pyrimidinylmethyl)acetamide
[(8S,9S,10R)-9-[4-[(E)-2-phenylethenyl]phenyl]-6-thiophen-2-ylsulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8R,9R,10S)-9-[4-[(E)-2-phenylethenyl]phenyl]-6-thiophen-2-ylsulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8S,9R,10R)-9-[4-[(E)-2-phenylethenyl]phenyl]-6-thiophen-2-ylsulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
2-[(3S,6aS,8R,10aS)-1-(3-fluorophenyl)sulfonyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-pyrimidinylmethyl)acetamide
2-[(3S,6aS,8S,10aS)-1-(3-fluorophenyl)sulfonyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-pyrimidinylmethyl)acetamide
[(8R,9S,10R)-9-[4-[(E)-2-phenylethenyl]phenyl]-6-thiophen-2-ylsulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
4-(3,4-Dimethoxybenzoyl)-5-(4-ethoxy-3-methoxyphenyl)-1-(5-methyl-1,2-oxazol-3-yl)pyrrolidine-2,3-dione
3-[[5-[(2-amino-1,3-thiazol-4-yl)methyl]-4-ethyl-1,2,4-triazol-3-yl]sulfanylmethyl]-N-(4-ethoxyphenyl)benzamide
3-[[5-[(2-amino-1,3-thiazol-4-yl)methyl]-4-ethyl-1,2,4-triazol-3-yl]sulfanylmethyl]-N-(3-ethoxyphenyl)benzamide
(2S,3R,4S)-4-[(E)-2-[1-(carboxymethyl)pyridin-1-ium-3-yl]ethenyl]-3-ethenyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-5-carboxylic acid
spectinomycin hydrochloride hydrate
A hydrate that is the pentahydrate form of spectinomycin hydrochloride. An antibiotic that is active against gram-negative bacteria and used to treat gonorrhea.
CCG273441
C26H24ClFN4O3 (494.15208759999996)
CCG273441 is a covalent inhibitor of G protein-coupled receptor (GPCR) kinase 5 (GRK5) with an IC50 value of 3.8 nM. CCG273441 is highly selective to GRK5 over GRK2 (IC50=4.8 μM) by binding Cys474, a GRK5 subfamily-specific residue, as a covalent handle[1].
ML380
C23H25F3N4O3S (494.15993760000003)
ML380 is a potent, subtype-selective, and brain-penetrant positive allosteric modulator (PAM) of M5 mAChR, with EC50s of 190 and 610 nM for human and rat M5, respectively. ML380 exhibits moderate selectivity versus the M1 and M3 mAChR subtypes. ML380 could increase the affinity of ACh for the M5 mAChR[1][2][3].